Clinical Trials

237 enrolled

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT01995942 2018-09-14

MARVEL

246 enrolled

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

Phase 1/2 Unknown

60 enrolled

Adenocarcinoma, Carcinoma, Squamous Cell

NCT03591666 2018-07-19

A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

51 enrolled

Adenocarcinoma, Recurrence

NCT02125240 2018-07-16

ICWIP

Phase 3 Unknown

124 enrolled

Adenocarcinoma

NCT02980536 2018-07-11

cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China

129 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT02863471 2017-10-31

PanHIPEC

Phase 1/2 Unknown

16 enrolled

Adenocarcinoma

NCT01952951 2017-09-13

PREPARE

110 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT01930864 2017-06-22

Metformin Plus Irinotecan for Refractory Colorectal Cancer

41 enrolled

Adenocarcinoma, Colorectal Neoplasms

NCT01665417 2017-02-08

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Adenocarcinoma

NCT02422628 2016-12-14

Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC

400 enrolled

Adenocarcinoma, Lung Neoplasms

NCT02951637 2016-11-01

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

300 enrolled

Adenocarcinoma of Lung, Adenocarcinoma

NCT01927328 2016-10-28

IRON

Classical hematologyGastrointestinal

40 enrolled

Adenocarcinoma, Anemia, Esophageal Neoplasms, Stomach Neoplasms

NCT02788669 2016-06-02

LRP1 and Colon Cancer

Adenocarcinoma, Colonic Neoplasms

NCT02755337 2016-04-28

EVALUATE

70 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT02738684 2016-04-14

A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test

Adenocarcinoma of Lung, Adenocarcinoma, Lung Neoplasms

NCT02103257 2015-04-29

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

192 enrolled

Adenocarcinoma

NCT02194556 2014-07-18

Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC

Adenocarcinoma

NCT01182246 2014-04-23

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Phase 1/2 Unknown

44 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT01984580 2013-11-14

Effect of Zinc on Barrett's Metaplasia

Phase 1 Unknown

120 enrolled

Adenocarcinoma, Barrett Esophagus

NCT01921699 2013-08-13

Macrophages Effect on Chemoresistance

Phase NA Unknown

2 enrolled

Adenocarcinoma

NCT01837173 2013-04-23

ECLNI-MC

2,000 enrolled

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT01739465 2013-02-26

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

Phase 2/3 Unknown

120 enrolled

Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, Carcinoma, Constriction, Pathologic, Digestive System Diseases, Neoplasms, Neoplasms by Site, Cholangiocarcinoma

NCT01523015 2013-02-05

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Phase 2/3 Unknown

Adenocarcinoma

NCT01502202 2012-06-20

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

162 enrolled

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT01590498 2012-05-04

Radiotherapy vs Observation for CRPC

2,000 enrolled

Genitourinary

Adenocarcinoma, Carcinoma, Prostatic Diseases, Prostatic Neoplasms

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

40 enrolled

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT01552967 2012-03-28

mXELOX

30 enrolled

Adenocarcinoma, Colorectal Neoplasms

NCT01552980 2012-03-28

mSOX

30 enrolled